These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1458050)

  • 21. Efficacy of anti-CD5 F(ab')2 and Fab' immunoconjugates in human peripheral blood lymphocyte-reconstituted severe combined immunodeficient mice.
    Kohn FR; Fishwild DM; Bernhard SL; Better M; Kung AH
    Int J Immunopharmacol; 1993 Nov; 15(8):871-8. PubMed ID: 7504661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thioether-bonded constructs of Fab'gamma and Fc gamma modules utilizing differential reduction of interchain disulfide bonds.
    Kan KS; Anderson VA; Leong WS; Smith AM; Worth AT; Stevenson GT
    J Immunol; 2001 Jan; 166(2):1320-6. PubMed ID: 11145716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production of F(ab')
    Rosenstein S; Vaisman-Mentesh A; Levy L; Kigel A; Dror Y; Wine Y
    Curr Protoc Mol Biol; 2020 Jun; 131(1):e119. PubMed ID: 32319727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purification of F(ab')2 anti-snake venom by caprylic acid: a fast method for obtaining IgG fragments with high neutralization activity, purity and yield.
    dos Santos MC; D'Império Lima MR; Furtado GC; Colletto GM; Kipnis TL; Dias da Silva W
    Toxicon; 1989; 27(3):297-303. PubMed ID: 2728022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification of antibody Fab and F(ab')2 fragments using Gradiflow technology.
    Cheung GL; Thomas TM; Rylatt DB
    Protein Expr Purif; 2003 Nov; 32(1):135-40. PubMed ID: 14680950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient production of a functional mouse/human chimeric Fab' against human urokinase-type plasminogen activator by Bacillus brevis.
    Inoue Y; Ohta T; Tada H; Iwasa S; Udaka S; Yamagata H
    Appl Microbiol Biotechnol; 1997 Oct; 48(4):487-92. PubMed ID: 9390457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Streptococcal protein G has affinity for both Fab- and Fc-fragments of human IgG.
    Erntell M; Myhre EB; Sjöbring U; Björck L
    Mol Immunol; 1988 Feb; 25(2):121-6. PubMed ID: 3131664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generating and Purifying Fab Fragments from Human and Mouse IgG Using the Bacterial Enzymes IdeS, SpeB and Kgp.
    Sjögren J; Andersson L; Mejàre M; Olsson F
    Methods Mol Biol; 2017; 1535():319-329. PubMed ID: 27914089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Three-step purification of preparative-scale antiCD20 (Fab')2].
    Wang JH; Yang M; Fan DM; Xu YS; Xiong DS; Yang CZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Oct; 30(5):622-5. PubMed ID: 19024400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation of F(ab')2 fragments from monoclonal mouse IgG1 suitable for use in radioimaging.
    Kurkela R; Vuolas L; Vihko P
    J Immunol Methods; 1988 Jun; 110(2):229-36. PubMed ID: 3132507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction and purification of domain-deleted immunoglobulin variants of the recombinant/chimeric B72.3 (y1) monoclonal antibody.
    Calvo B; Kashmiri SV; Hutzell P; Hand PH; Slavin-Chiorini DC; Schlom J; Zaremba S
    Cancer Biother; 1993; 8(1):95-109. PubMed ID: 7529083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How to make bispecific antibodies.
    French RR
    Methods Mol Med; 2000; 40():333-9. PubMed ID: 21337104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Site-specific conjugation of bifunctional chelator BAT to mouse IgG1 Fab' fragment.
    Li J; Wang XH; Wang XM; Chen ZL
    Acta Pharmacol Sin; 2006 Feb; 27(2):237-41. PubMed ID: 16412275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stable expression and purification of a functional processed Fab' fragment from a single nascent polypeptide in CHO cells expressing the mCAT-1 retroviral receptor.
    Camper N; Byrne T; Burden RE; Lowry J; Gray B; Johnston JA; Migaud ME; Olwill SA; Buick RJ; Scott CJ
    J Immunol Methods; 2011 Sep; 372(1-2):30-41. PubMed ID: 21782818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal conditions for the preparation of Fab and F(ab')2 fragments from monoclonal IgG of different rat IgG subclasses.
    Rousseaux J; Rousseaux-Prévost R; Bazin H
    J Immunol Methods; 1983 Nov; 64(1-2):141-6. PubMed ID: 6644029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. F(ab')2 molecules made from Escherichia coli produced Fab' with hinge sequences conferring increased serum survival in an animal model.
    Humphreys DP; Vetterlein OM; Chapman AP; King DJ; Antoniw P; Suitters AJ; Reeks DG; Parton TA; King LM; Smith BJ; Lang V; Stephens PE
    J Immunol Methods; 1998 Aug; 217(1-2):1-10. PubMed ID: 9776570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Fab region of IgG2 human myeloma proteins does not bear the streptococcal protein G-specific determinant.
    Perosa F; Luccarelli G; Neri M; Dammacco F
    J Immunol Methods; 1997 Apr; 203(2):153-5. PubMed ID: 9149808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered glomerular permeability induced by F(ab')2 and Fab' antibodies to rat renal tubular epithelial antigen.
    Salant DJ; Madaio MP; Adler S; Stilmant MM; Couser WG
    Kidney Int; 1982 Jan; 21(1):36-43. PubMed ID: 7043051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The enhancement of cytolytic activity in lymphokine activated killer cells using bispecific F(ab')2].
    Azuma A
    Nihon Ika Daigaku Zasshi; 1991 Dec; 58(6):663-72. PubMed ID: 1663120
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.